Evidence map›Paper›PMID 37669378›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Systems-level temporal immune-metabolic profile in Crimean-Congo hemorrhagic fever virus infection.

Anoop T Ambikan, Nazif Elaldi, Sara Svensson-Akusjärvi, Binnur Bagci, Ayse Nur Pektas, Roger Hewson, Gokhan Bagci, Mehmet Arasli, Sofia Appelberg, Adil Mardinoglu and 7 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Observational
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 4 countries.

Anoop T Ambikan *The Systems Virology Lab, Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, ANA Futura, Stockholm-14152, Sweden.
Nazif Elaldi *Department of Infectious Diseases and Clinical Microbiology, Medical Faculty, Sivas Cumhuriyet University, Sivas 58140, Turkey.ORCID 0000-0002-9515-770X
Sara Svensson-AkusjärviThe Systems Virology Lab, Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, ANA Futura, Stockholm-14152, Sweden.ORCID 0000-0002-1086-5409
Binnur BagciDepartment of Nutrition and Dietetics, Faculty of Health Sciences, Sivas Cumhuriyet University, Sivas, Turkey.
Ayse Nur PektasCumhuriyet University Advanced Technology Application and Research Center, Sivas Cumhuriyet University, Sivas 58140, Turkey.ORCID 0000-0001-5621-2844
Roger HewsonUnited Kingdom Health Security Agency, Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom.ORCID 0000-0003-2273-3152
Gokhan BagciDepartment of Biochemistry, Faculty of Medicine, Altinbas University, Istanbul 34147, Turkey.ORCID 0000-0003-4554-2391
Mehmet ArasliDepartment of Immunology, Medical Faculty, Bulent Ecevit University, Zonguldak 67600, Turkey.ORCID 0000-0002-5931-419X
Sofia AppelbergPublic Health Agency of Sweden, Solna, Stockholm-17165, Sweden.ORCID 0000-0002-7381-3606
Adil MardinogluScience for Life Laboratory, Kungliga Tekniska Högskolan-Royal Institute of Technology, Stockholm-17121, Sweden.ORCID 0000-0002-4254-6090
Vikas SoodThe Systems Virology Lab, Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, ANA Futura, Stockholm-14152, Sweden.ORCID 0000-0001-6128-4279
Ákos VégváriDivision of Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm-17177, Sweden.ORCID 0000-0002-1287-0906
Rui BenfeitasThe Systems Virology Lab, Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, ANA Futura, Stockholm-14152, Sweden.
Soham GuptaThe Systems Virology Lab, Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, ANA Futura, Stockholm-14152, Sweden.ORCID 0000-0003-1136-3010
Ilhan CetinDepartment of Public Health, Medical Faculty, Sivas Cumhuriyet University, Sivas 58140, Turkey.
Ali MirazimiPublic Health Agency of Sweden, Solna, Stockholm-17165, Sweden.
Ujjwal NeogiThe Systems Virology Lab, Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, ANA Futura, Stockholm-14152, Sweden.ORCID 0000-0002-0844-3338
Karolinska Institutet · SESivas Cumhuriyet Üniversitesi · TRPublic Health Agency of Sweden · SEAltınbaş University · TRBülent Ecevit University · TRJamia Hamdard · INKing's College London · GBUniversity of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crimean-Congo hemorrhagic fever (CCHF) caused by CCHF virus (CCHFV) is one of the epidemic-prone diseases prioritized by the World Health Organisation as public health emergency with an urgent need for accelerated research. The trajectory of host response against CCHFV is multifarious and remains unknown. Here, we reported the temporal spectrum of pathogenesis following the CCHFV infection using genome-wide blood transcriptomics analysis followed by advanced systems biology analysis, temporal immune-pathogenic alterations, and context-specific progressive and postinfection genome-scale metabolic models (GSMM) on samples collected during the acute (T0), early convalescent (T1), and convalescent-phase (T2). The interplay between the retinoic acid-inducible gene-I-like/nucleotide-binding oligomerization domain-like receptor and tumor necrosis factor signaling governed the trajectory of antiviral immune responses. The rearrangement of intracellular metabolic fluxes toward the amino acid metabolism and metabolic shift toward oxidative phosphorylation and fatty acid oxidation during acute CCHFV infection determine the pathogenicity. The upregulation of the tricarboxylic acid cycle during CCHFV infection, compared to the noninfected healthy control and between the severity groups, indicated an increased energy demand and cellular stress. The upregulation of glycolysis and pyruvate metabolism potentiated energy generation through alternative pathways associated with the severity of the infection. The downregulation of metabolic processes at the convalescent phase identified by blood cell transcriptomics and single-cell type proteomics of five immune cells (CD4

Indexed as

Hemorrhagic Fever, CrimeanHemorrhagic Fever Virus, Crimean-CongoCD8-Positive T-LymphocytesHumansMetabolomeUp-RegulationCrimean-Congo hemorrhagic fever virusgenome-scale metabolic modelspost viral fatigue

Identifiers

PMID37669378
PMCPMC10500270
OpenAlexW4386452933

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.